Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jounce Therapeutics Inc.

    NASDAQ: JNCE · Real-Time Price · USD
    1.88
    0.00 (0.00%)
    At close: May 03, 2023, 10:00 PM

    Jounce Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 82M 26.91 26.91 25.37M 26.91M 89.25M 89.25M 63.88M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 82M 26.91 26.91 25.37M 26.91M 89.25M 89.25M 63.88M
    Operating Income
    		 -52.24M -102.55M -101.29M -71.62M -60.74M -25.35M -20.32M -44.52M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -50.78M -101.83M -100.92M -71.43M -60.6M -25.16M -19.97M -43.93M
    Net Income
    		 -50.92M -101.85M -100.94M -71.44M -60.61M -25.17M -19.98M -43.93M
    Selling & General & Admin
    		 30.97M 22.5M 21.71M 21.51M 21.78M 28.68M 28.93M 28.84M
    Research & Development
    		 103.27M 80.05M 79.58M 75.48M 65.87M 85.91M 80.63M 79.55M
    Other Expenses
    		 309K 309K 309K 96K n/a n/a n/a n/a
    Operating Expenses
    		 134.24M 102.55M 101.29M 96.99M 87.65M 114.6M 109.56M 108.39M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 134.24M 102.55M 101.29M 96.99M 87.65M 114.6M 109.56M 108.39M
    Income Tax Expense
    		 135K 17.99K 18.99K 8.99K 8.99K -4.99K -8.99K -6.99K
    Shares Outstanding (Basic)
    		 51.68M 51.69M 51.68M 51.64M 51.25M 51.23M 51.21M 45.96M
    Shares Outstanding (Diluted)
    		 51.68M 51.69M 51.68M 51.64M 51.25M 51.23M 51.21M 45.96M
    EPS (Basic)
    		 -0.98 -1.97 -1.96 -1.39 -1.25 -0.35 -0.49 -1.23
    EPS (Diluted)
    		 -0.98 -1.97 -1.96 -1.39 -1.25 -0.39 -0.53 -1.27
    EBITDA
    		 -50.16M -100.26M -98.76M -68.9M -57.77M -22.19M -16.88M -40.69M
    EBIT
    		 -52.24M -102.55M -101.29M -71.62M -60.74M -25.35M -20.32M -16.27M
    Depreciation & Amortization
    		 2.09M 2.29M 2.48M 2.63M 2.83M 2.98M 3.11M 3.25M

    Add to Watchlist